Atlas Trials

A Study to Learn More About How Radium-223 Affects the Quality of Life of Colombian Patients With Prostate Cancer That Has Not Responded to Testosterone Lowering Treatment and Has Spread to the Bones, and to Better Understand Its Safety

Clinical trial NCT04681144 · COMPLETED

Trial details

NCT number
NCT04681144
Sponsor
Bayer
Status
COMPLETED
Study type
OBSERVATIONAL
Prostate Cancer
Start date
2021-04-08
Primary completion
2022-11-21
Enrollment
103

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.